Anthropic has reportedly established a physical biology laboratory in the San Francisco Bay Area as the artificial intelligence firm, aiming to expand its work in life sciences and drug research.
Anthropic moves beyond computer-based research
As per Reuters, the Claude AI manufacturer’s new “wet lab” lets scientists conduct physical biology experiments instead of depending only on computer-based or “in silico” analysis.
Anthropic’s head of life sciences, Eric Kauderer-Abrams, confirmed that the company is already carrying out work in its own facilities while also partnering with external organizations.
Eric Kauderer-Abrams stated, "We believe that to do biology, the final test is still and will be for a while in real lab work," he said. "We absolutely are doing that today, and I would describe our approach as being typical of what you would see in most biotech companies, where there's some amount of that that we're doing in our own facilities and some amount of that that we're working with external partners on.”
However, an Anthropic spokesperson clarified that the laboratory is not primarily focused on drug discovery.
The company has previously said it wants to use AI to help address rare and difficult-to-treat diseases. It is focusing on preclinical research in areas that traditional pharmaceutical companies may consider less financially attractive.
Previously, Anthropic stated it wants to use AI to assist in acknowledging difficult-to-treat disorders and rare diseases.
The recently established lab aims to see how much of the physical work involved in scientific experiments can eventually be automated, although the company says humans will remain involved for safety.
Claude could help automate experiments
Moreover, the company is exploring several ways for its Claude AI system to direct robotic laboratory equipment and perform scientific experiments with limited human intervention.
"We're in the very early innings of using AI to automate the execution of lab work. An area that has the potential to bring about meaningful acceleration in so many different processes," Kauderer-Abrams added.
Alongside the lab, Anthropic also developed tools intended to assist AI systems interact with laboratory equipment as part of its broader life-sciences strategy.
AI safety concerns remain
Anthropic’s expansion into the laboratory comes as the company faces increasing concerns regarding the possible risks of the cutting-edge AI.
Several researchers have issued a warning regarding extreme AI risks, while the company has reported instances in which its systems could potentially be misused in biological weapons development.
